Cargando…

Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears

PURPOSE: To report a case of bacterial keratitis caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa strain linked to contaminated artificial tears in the United States. The ulcer was successfully treated without perforation or extracorneal spread. OBSERVATIONS: An 81-year-old patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Sina, Steen, Daniel, Amin, Sejal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407592/
https://www.ncbi.nlm.nih.gov/pubmed/37560556
http://dx.doi.org/10.1016/j.ajoc.2023.101909
_version_ 1785085999730130944
author Rezaei, Sina
Steen, Daniel
Amin, Sejal
author_facet Rezaei, Sina
Steen, Daniel
Amin, Sejal
author_sort Rezaei, Sina
collection PubMed
description PURPOSE: To report a case of bacterial keratitis caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa strain linked to contaminated artificial tears in the United States. The ulcer was successfully treated without perforation or extracorneal spread. OBSERVATIONS: An 81-year-old patient presented with a corneal ulcer of the right eye. The patient had a notable complex ocular history including glaucoma and corneal edema from corneal decompensation after prolonged retained lens fragment. Despite starting hourly fortified tobramycin and vancomycin eye drops, the infiltrate grew significantly by the next day. Bacterial culture grew Pseudomonas aeruginosa that was resistant to all tested antibiotics except for intermediate susceptibility to colistin and susceptibility to cefiderocol. Tobramycin-soaked collagen shields were applied daily for three days, and the patient was started on fortified colistin eye drops. The ulcer improved and, after seven weeks of therapy, the infiltrate resolved and resulted in a large central corneal scar. CONCLUSIONS AND IMPORTANCE: A combination of fortified colistin and tobramycin (administered via a combination of fortified eye drops and tobramycin-soaked collagen shields) appears to be an effective treatment option for extensively drug-resistant Pseudomonas aeruginosa corneal ulcers.
format Online
Article
Text
id pubmed-10407592
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104075922023-08-09 Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears Rezaei, Sina Steen, Daniel Amin, Sejal Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of bacterial keratitis caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa strain linked to contaminated artificial tears in the United States. The ulcer was successfully treated without perforation or extracorneal spread. OBSERVATIONS: An 81-year-old patient presented with a corneal ulcer of the right eye. The patient had a notable complex ocular history including glaucoma and corneal edema from corneal decompensation after prolonged retained lens fragment. Despite starting hourly fortified tobramycin and vancomycin eye drops, the infiltrate grew significantly by the next day. Bacterial culture grew Pseudomonas aeruginosa that was resistant to all tested antibiotics except for intermediate susceptibility to colistin and susceptibility to cefiderocol. Tobramycin-soaked collagen shields were applied daily for three days, and the patient was started on fortified colistin eye drops. The ulcer improved and, after seven weeks of therapy, the infiltrate resolved and resulted in a large central corneal scar. CONCLUSIONS AND IMPORTANCE: A combination of fortified colistin and tobramycin (administered via a combination of fortified eye drops and tobramycin-soaked collagen shields) appears to be an effective treatment option for extensively drug-resistant Pseudomonas aeruginosa corneal ulcers. Elsevier 2023-07-28 /pmc/articles/PMC10407592/ /pubmed/37560556 http://dx.doi.org/10.1016/j.ajoc.2023.101909 Text en © 2023 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Rezaei, Sina
Steen, Daniel
Amin, Sejal
Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
title Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
title_full Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
title_fullStr Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
title_full_unstemmed Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
title_short Successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
title_sort successful treatment of an extensively drug-resistant pseudomonal ulcer associated with contaminated artificial tears
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407592/
https://www.ncbi.nlm.nih.gov/pubmed/37560556
http://dx.doi.org/10.1016/j.ajoc.2023.101909
work_keys_str_mv AT rezaeisina successfultreatmentofanextensivelydrugresistantpseudomonalulcerassociatedwithcontaminatedartificialtears
AT steendaniel successfultreatmentofanextensivelydrugresistantpseudomonalulcerassociatedwithcontaminatedartificialtears
AT aminsejal successfultreatmentofanextensivelydrugresistantpseudomonalulcerassociatedwithcontaminatedartificialtears